Bloomage Biotech

Bloomage Biotech is the global volume leader in medical-grade hyaluronic acid, supplying dermal fillers, ophthalmic and orthopedic injectables, and is pivoting into glycoscience and AI-designed glycans;…

Country
China
Ticker
SSE:688363
Biomaterials NMPA registered cn
Coverage
CNEUUS
regenerative-personalized
specialty-fine-chem
Regulatorsfdanmpareachema

Verifiable facts

FactValueSource
FundingNot specified in provided sourcesapp.dealroom.co
Capacity1,000 tons total planned capacity for bioactive materials (pilot platform)bloomagebioactive.com
CertificationECOCERT, COSMOS, VEGAN (cosmetic grade); EU CEP, FDA GMP (pharmaceutical grade); Kosher, Halal (food grade)bloomagebioactive.com
Regulatory approvalUS FDA (multiple inspections), EU CEP, Japan MF/PMDA, Korea MFDS, Canada DMF, China NMPA (Class III medical devices)biospace.com · bloomagebioactive.com
Production siteJinan, Haikou, Tianjin, Dongying, Xiangtanvip.stock.finance.sina.com.cn · bloomagebioactive.com
Revenue5.371 billion yuan (2024)yicaiglobal.com

Independent sources: app.dealroom.co · biospace.com · bloomagebioactive.com · vip.stock.finance.sina.com.cn · yicaiglobal.com

Technologies
NameClusterRisk
Biomedical engineering & implantsregenerative-personalizedMedium
Biosynthetic hyaluronic acidspecialty-fine-chemLow
Cosmetics, nutricosmetics & wellnessspecialty-fine-chemLow

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.